drugset / Trial / NCT04821804

Local Application of Hyaluronic Acid (HYADENT BG) With Free Soft Tissue Grafing Improves Treatment Outcomes.

NCT04821804

Phase 2/3 Completed 24 enrolled Jordan University of Science and Technology
RandomizedParallel-groupSingle-blindTreatment

Summary

A total of 24 healthy non-smoker patients requiring FGG recruited for the study. Subjects were equally and randomly assigned into two groups. Test group, local application of HYADENT BG on both donor and recipient sites. Control group, application of normal saline on both sites as placebo. The FGG dimensions were evaluated at 1, 3- and 6-month recall using digital photographs. Post-operative pain was evaluated for 14 days. Color matching and patient satisfaction were evaluated at 6 months.

Timeline

Start
2020-01-02
Primary completion
2020-09-01
Completion
2020-09-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyaluronic Acid Other / unclassified Topical

Indications